Heart failure is a chronic, degenerative condition with a very high incidence, affecting 64 million people worldwide. The high costs related to patient care, monitoring and treatment necessitates new means and technologies to tackle this condition. In this context, the FORESEE project, coordinated by Dr. Laura Becerra-Fajardo, a researcher with the Biomedical Electronics Research Group (BERG) of the BCN MedTech Research Unit at UPF (TECNIO centre), together with Prof. Antoni Ivorra, head of BERG, as technological development coordinator, proposes to continue developing an intravascular sensor to monitor heart failure patients remotely. This innovative microsensing medical device, which is protected by two patent applications, may prove an enormous opportunity for health systems to optimize the medical management and treatment of this condition, improving patients’ quality of life and thus contributing to reducing the mortality rate, which currently stands at 50% five years after diagnosis.

The revolutionary nature of this technology has been recognized in the European call, EIC Transition Open, a programme that funds new technologies in any scientific field that have passed a proof of concept in the laboratory and aim to validate and demonstrate the technology in an environment relevant to its application in order to develop a solution for the market. This year’s call received 131 submissions from 26 different countries of which 14 have been selected, including the FORESEE project, which will receive funding of €2.5m over three years. 

Continue reading the full UPF news.